Results for tag: "Zika Drug"

The Zika Drug market is a subset of the larger Infectious Diseases Drugs market. It is composed of drugs and treatments specifically designed to combat the Zika virus, a mosquito-borne virus that can cause severe birth defects in newborns. The market is relatively small compared to other infectious diseases, but is growing as the virus continues to spread. The Zika Drug market is composed of both traditional and novel treatments. Traditional treatments include antiviral drugs, which are used to reduce the severity of symptoms and shorten the duration of the virus. Novel treatments include vaccines, which are designed to prevent the virus from spreading. The Zika Drug market is highly competitive, with many companies vying for a share of the market. Companies in the market include Sanofi, GlaxoSmithKline, Merck, and Pfizer. Show Less Read more